12:00 AM
 | 
Aug 01, 2011
 |  BC Week In Review  |  Company News  |  Deals

Eurospital S.p.A., Hycor deal

Eurospital granted Hycor non-exclusive rights outside of the U.S. and Canada to Eurospital's transglutaminase...

Read the full 60 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >